These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31716)

  • 1. Ocular effects of beta-blocking therapy.
    Macrae JA
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(4):510-3. PubMed ID: 31716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
    Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
    Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining.
    Korb DR; Herman JP; Finnemore VM; Exford JM; Blackie CA
    Eye Contact Lens; 2008 Jan; 34(1):61-4. PubMed ID: 18180687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Review: beta-blocking agents in dermatology (author's transl)].
    Clerens A; Guilmot-Bruneau MM; Defresne C; Bourlond A
    Dermatologica; 1981; 163(1):5-11. PubMed ID: 6115777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.
    Mackie IA; Seal DV; Pescod JM
    Br J Ophthalmol; 1977 May; 61(5):354-9. PubMed ID: 17431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to beta-blocking drugs: a review.
    Petrie JC; Galloway DB; Jeffers TA; Webster J
    Postgrad Med J; 1976; 52 Suppl 4():63-9. PubMed ID: 9632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practolol and the safety of other beta blockers.
    Sutherland DC; Wilson JD
    N Z Med J; 1976 Oct; 84(573):282-5. PubMed ID: 12491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis.
    Dogru M; Okada N; Asano-Kato N; Igarashi A; Fukagawa K; Shimazaki J; Tsubota K; Fujishima H
    Clin Exp Allergy; 2006 Dec; 36(12):1556-65. PubMed ID: 17177679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-adrenergic blocking agents and ventilatory function. Clinical aspects].
    Monteiro-Trindade A; Costa-Trindade J; Palma-Carlos AG; de Padua F
    Cah Med; 1973 Oct; 14(11):949-57. PubMed ID: 4151122
    [No Abstract]   [Full Text] [Related]  

  • 10. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
    Goldstein S
    Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis provoked by beta-blocking agents.
    Arntzen N; Kavli G; Volden G
    Acta Derm Venereol; 1984; 64(4):346-8. PubMed ID: 6209897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Goblet cells density of bulbar conjunctiva after long-term topical antiglaucoma agents].
    Wróblewska E
    Klin Oczna; 1999; 101(1):45-7. PubMed ID: 10401215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
    Wright P
    Br Med J; 1975 Mar; 1(5958):595-8. PubMed ID: 1125623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.
    Dogru M; Matsumoto Y; Okada N; Igarashi A; Fukagawa K; Shimazaki J; Tsubota K; Fujishima H
    Allergy; 2008 Oct; 63(10):1324-34. PubMed ID: 18782111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of beta blockaders on ventilatory function in chronic bronchitis].
    Hugues FC; Julien D; Marche J
    Arch Mal Coeur Vaiss; 1979 Jan; 72(1):92-7. PubMed ID: 35114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival and corneal stainability with Bengal rose after instillation of local anesthetics in human eyes.
    KRONNING E
    Am J Ophthalmol; 1954 Sep; 38(3):351-61. PubMed ID: 13188938
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers.
    Dogru M; Asano-Kato N; Tanaka M; Igarashi A; Shimmura S; Shimazaki J; Okada N; Takano Y; Fukagawa K; Tsubota K; Fujishima H
    Curr Eye Res; 2005 Oct; 30(10):897-908. PubMed ID: 16251127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.